Pali D. Shah

4.5k total citations
94 papers, 1.7k citations indexed

About

Pali D. Shah is a scholar working on Surgery, Transplantation and Epidemiology. According to data from OpenAlex, Pali D. Shah has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Surgery, 37 papers in Transplantation and 25 papers in Epidemiology. Recurrent topics in Pali D. Shah's work include Transplantation: Methods and Outcomes (81 papers), Renal Transplantation Outcomes and Treatments (36 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Pali D. Shah is often cited by papers focused on Transplantation: Methods and Outcomes (81 papers), Renal Transplantation Outcomes and Treatments (36 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Pali D. Shah collaborates with scholars based in United States, Canada and Thailand. Pali D. Shah's co-authors include Christian A. Merlo, Jonathan B. Orens, John F. McDyer, Ashish S. Shah, Robin K. Avery, Arman Kilic, Errol L. Bush, Shmuel Shoham, Mary Armanios and Scott M. Palmer and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Pali D. Shah

86 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pali D. Shah United States	26	967	455	446	336	223	94	1.7k
Gundeep Dhillon United States	27	1.2k 1.2×	421 0.9×	818 1.8×	500 1.5×	284 1.3×	72	2.1k
Jasleen Kukreja United States	25	1.1k 1.2×	392 0.9×	878 2.0×	315 0.9×	221 1.0×	128	2.1k
Sangeeta Bhorade United States	28	1.1k 1.2×	578 1.3×	690 1.5×	597 1.8×	300 1.3×	97	2.3k
Martin Iversen Denmark	28	1.4k 1.4×	652 1.4×	1.1k 2.4×	574 1.7×	302 1.4×	104	2.5k
G. Snell Australia	22	1.1k 1.1×	525 1.2×	357 0.8×	413 1.2×	142 0.6×	88	1.5k
K. McNeil United Kingdom	18	736 0.8×	178 0.4×	575 1.3×	373 1.1×	161 0.7×	54	1.3k
Thomas Fuehner Germany	17	829 0.9×	183 0.4×	435 1.0×	316 0.9×	75 0.3×	53	1.2k
Brian Feingold United States	21	808 0.8×	470 1.0×	211 0.5×	327 1.0×	135 0.6×	111	1.7k
Isabel P. Neuringer United States	21	766 0.8×	264 0.6×	673 1.5×	186 0.6×	311 1.4×	46	1.4k
Christian Ducerf France	29	1.8k 1.8×	379 0.8×	460 1.0×	1.5k 4.3×	478 2.1×	138	3.5k

Countries citing papers authored by Pali D. Shah

Since Specialization

Citations

This map shows the geographic impact of Pali D. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pali D. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pali D. Shah more than expected).

Fields of papers citing papers by Pali D. Shah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pali D. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pali D. Shah. The network helps show where Pali D. Shah may publish in the future.

Co-authorship network of co-authors of Pali D. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Pali D. Shah. A scholar is included among the top collaborators of Pali D. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pali D. Shah. Pali D. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruck, Jessica M., Alice L. Zhou, Dorry L. Segev, et al.. (2024). Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis. SHILAP Revista de lepidopterología. 3(1). 133–137.

Ruck, Jessica M., Ramon Riojas, Pali D. Shah, et al.. (2024). Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy. SHILAP Revista de lepidopterología. 7. 100201–100201.

Todd, Jamie L., Jeremy M. Weber, Francine L. Kelly, et al.. (2024). Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 44(3). 320–328.

Deshpande, Mukund, et al.. (2024). Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 5. 1339911–1339911. 5 indexed citations

Zhou, Alice L., Jessica M. Ruck, Benjamin L. Shou, et al.. (2023). Early United States experience with lung donation after circulatory death using thoracoabdominal normothermic regional perfusion. The Journal of Heart and Lung Transplantation. 42(6). 693–696. 30 indexed citations

Zhou, Alice L., Jessica M. Ruck, Eric Etchill, et al.. (2023). The effect of allograft ischemic time on outcomes following bilateral, single, and reoperative lung transplantation. Journal of Thoracic and Cardiovascular Surgery. 167(2). 556–565.e8. 5 indexed citations

Keller, Michael, Yang Song, A. Cochrane, et al.. (2023). Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death. American Journal of Transplantation. 23(4). 559–564. 16 indexed citations

Villabona-Rueda, A.F., Samantha A. Whiteside, Sean Agbor-Enoh, et al.. (2023). Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients. The Journal of Heart and Lung Transplantation. 42(9). 1166–1174. 4 indexed citations

Permpalung, Nitipong, Tao Liang, Darin Ostrander, et al.. (2023). Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year. The Journal of Heart and Lung Transplantation. 42(7). 953–963. 5 indexed citations

10.

Chidi, Alexis P., Yi Liu, Jessica M. Ruck, et al.. (2023). Racial Disparities in Waiting List Outcomes of Patients Listed for Lung Transplantation. The Annals of Thoracic Surgery. 117(3). 619–626. 3 indexed citations

11.

Keller, Michael B., Xin Tian, Moon Kyoo Jang, et al.. (2023). Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection. The Journal of Heart and Lung Transplantation. 43(4). 563–570. 3 indexed citations

12.

Permpalung, Nitipong, Robin K. Avery, Hyesik Kong, et al.. (2022). Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction. American Journal of Transplantation. 22(11). 2560–2570. 23 indexed citations

13.

Cochrane, A., Deborah J. Levine, Mary Carmelle Philogene, et al.. (2022). Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories. The Journal of Heart and Lung Transplantation. 42(2). 226–235. 8 indexed citations

14.

Garibaldi, Brian T., Pali D. Shah, Gigi Liu, et al.. (2020). Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. American Journal of Transplantation. 20(8). 2254–2259. 35 indexed citations

15.

Todd, Jamie L., Megan L. Neely, Heather Kopetskie, et al.. (2020). Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study. American Journal of Respiratory and Critical Care Medicine. 202(4). 576–585. 46 indexed citations

16.

Hoji, Aki, Iulia Popescu, Matthew R. Pipeling, et al.. (2019). Early KLRG1+ but Not CD57+CD8+ T Cells in Primary Cytomegalovirus Infection Predict Effector Function and Viral Control. The Journal of Immunology. 203(8). 2063–2075. 8 indexed citations

17.

Popescu, Iulia, H. Mannem, Spencer Winters, et al.. (2018). Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres. American Journal of Respiratory and Critical Care Medicine. 199(3). 362–376. 68 indexed citations

18.

Shah, Pali D., Qiong Zhong, Elizabeth A. Lendermon, Matthew R. Pipeling, & John F. McDyer. (2015). Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis. Viral Immunology. 28(5). 255–264. 2 indexed citations

19.

Grimm, Joshua C., Vicente Valero, Arman Kilic, et al.. (2014). Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation. The Annals of Thoracic Surgery. 99(2). 482–489. 30 indexed citations

20.

Christie, Jason D., Chirag V. Shah, Steven M. Kawut, et al.. (2009). Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction. American Journal of Respiratory and Critical Care Medicine. 180(10). 1010–1015. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact